Clinical Trial Update: Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML [Phase 1]

View source ↗

Summary

Phase I trial evaluating Velcade (bortezomib) in combination with idarubicin for elderly and relapsed acute myeloid leukemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Idamycin (idarubicin)
• Velcade (bortezomib)

Snippet

Sponsor: University of Kentucky | Conditions: Acute Myelogenous Leukemia | Phase 1 | Status: COMPLETED